Login
Nano Mobile Healthcare, Inc. logo

Nano Mobile Healthcare, Inc.

nanomobilehealthcare.com

No Longer Reporting

The company has not filed an annual or quarterly report since its Q1 FY2017 10-Q, filed Mar 16, 2018. Its latest SEC filing is a 8-K from Aug 3, 2026.

The sections below describe the company as of the FY2015 annual report.

What Did They Do?

Develops handheld breath-screening devices to detect disease and drug use for health care providers, law enforcement and other organizations.

Who Were Their Customers?

Medical diagnostic customers are expected to be health care providers; narcotics-screening customers include law enforcement, sports organizations and corporations.

How Were They Changing?

Since the FY2015 annual report
Latest quarter: Q1 FY2017, the three months to Sep 30, 2016
Net income
▼ Now a loss
vs $407.3K in Q1 FY2016
  • Aug 3, 2026 Signed an agreement for Neptune to become an operating subsidiary The agreement provides for Neptune to become wholly owned; the company also appointed a new chief executive, finance chief and board chair.
  • Sep 13, 2023 Roy Watson became chief executive after the control-sale agreement was canceled
  • Dec 2, 2022 Engaged a new independent auditor Haroon Imtiaz was engaged as the company's new independent registered public accounting firm.
  • Sep 16, 2022 Agreed to transfer control as buyer planned an electric vehicle charging pivot The buyer planned to steer the company into the electric vehicle charging-station business; Adam Matruski became president and chief executive.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support